Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Feb 5, 2024 (3 years ago)

Neptune's Fix

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

Neptune's Fix, Tianeptine Elixir, Fast Acting, 0.338 fl.oz. (10 mL) bottle, Distributed By Superchill Products, 827 6th Avenue, New York, New York 10001.

Recalling firm
Super Chill Products
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0393-2024 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other unapproved drug recalls from 2024

All unapproved drug recalls
Class II · Moderate risk

Ramipril Capsules USP 10 mg

CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

Terminated Unapproved drug Lupin Pharmaceuticals Inc. NDC 68180-591-09 D-0054-2025
Class II · Moderate risk

Ramipril Capsules USP 5 mg

CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

Terminated Unapproved drug Lupin Pharmaceuticals Inc. NDC 68180-590-09 D-0053-2025
Class II · Moderate risk

Ramipril Capsules USP 2.5 mg

CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

Terminated Unapproved drug Lupin Pharmaceuticals Inc. NDC 68180-589-09 D-0052-2025